SCHEMBL4670840

SCHEMBL4670840

O=C(NO)[C@H]1CCCCN1S(=O)(=O)N1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 6/20 0.60
MMP13 P45452 7/20 0.49
MMP7 P09237 4/20 0.49
MMP3 P08254 2/20 0.49
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 1/20 0.46
MMP2 P08253 4/20 0.46
MMP9 P14780 4/20 0.46
MMP8 P22894 7/20 0.45
MMP12 P39900 6/20 0.45
HPGD P15428 1/20 0.40
GAA P10253 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6264715 1.00 MMP1 (0.60) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL6267896 0.98 MMP1 (0.58) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL4673474 0.79 MMP1 (0.53) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL4674939 0.79 MMP1 (0.62) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL6267900 0.78 LMNA (0.56) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL6272542 0.78 MMP1 (0.61) MMP1MMP13MMP7MMP3MMP2
SCHEMBL4670789 0.78 LMNA (0.56) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL4670712 0.78 MMP1 (0.58) MMP1MMP13MMP7MMP3ALDH1A1
SCHEMBL4671354 0.78 MMP1 (0.68) MMP1MMP13MMP7MMP3MMP2
SCHEMBL4672960 0.78 MMP1 (0.61) MMP1MMP13MMP7MMP3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed
EP-0958287-A1 SULFAMIDE-METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1999-11-24 EP disclosed
WO-1998032748-A1 SULFAMIDE-METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1998-07-30 WO disclosed